Evidence map›Paper›PMID 34064880›Full record

ArticleInternational journal of environmental research and public health2021

Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy.

Ariel Bardach, Andrea Alcaraz, Javier Roberti, Agustín Ciapponi, Federico Augustovski, Andrés Pichon-Riviere

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Sex Differences in Cardiovascular Disease Mortality in Brazil between 1996 and 2019.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ariel BardachDepartment of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina.
Andrea AlcarazDepartment of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina.
Javier RobertiDepartment of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina.ORCID 0000-0002-4285-5061
Agustín CiapponiDepartment of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina.ORCID 0000-0001-5142-6122
Federico AugustovskiDepartment of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina.
Andrés Pichon-RiviereDepartment of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina.ORCID 0000-0001-6052-025X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn Latin America, tobacco smoking prevalence is between 6.4% and 35.2%. Governments have been making efforts to support the regulation of advertising and, in many cases, banning advertising and promotion of tobacco altogether. The objective of this study was to evaluate the potential impact on health and economic outcomes of optimizing a ban on tobacco advertising and sponsorship in Argentina, Bolivia, Brazil, Chile, Colombia, Mexico, and Peru.

methodsWe built a probabilistic microsimulation model, considering natural history, direct health system costs, and quality of life impairment associated with main tobacco-related diseases. We followed individuals in hypothetical cohorts and calculated health outcomes on an annual basis to obtain aggregated 10-year population health outcomes (deaths, events, healthy years of life) and costs. To populate the model, we performed a rapid review of literature to calculate intervention effectiveness.

resultsWith current policies, over 10 years, in Argentina, Bolivia, Brazil, Chile, and Colombia a total of 50,000 deaths and 364,000 disease events will be averted, saving $7.2 billion. If the seven countries strengthened their policies and implemented a comprehensive ban with 100% compliance, 98,000 deaths and 648,000 events would be averted over 10 years, saving almost $15 billion in healthcare costs.

conclusionsOptimizing a ban on tobacco advertising and sponsorship would substantially reduce deaths, diseases, and health care costs attributed to smoking. Latin American countries should not delay the full implementation of this strategy.

Indexed as

AdvertisingArgentinaBoliviaBrazilChileColombiaHumansLatin AmericaMexicoNicotianaPeruPolicyQuality of Lifeadvertising and sponsorship banfinancial benefitshealth benefitsLatin Americasmokingtobacco

Identifiers

PMID34064880
PMCPMC8151006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.